Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea · Delayed Price · Currency is KRW 6,070.00
+30.00 (0.50%)
At close: Sep 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Food | 628.43B | Log In | Log In | Log In | Log In | Upgrade |
Food Growth | 10.76% | Log In | Log In | Log In | Log In | Upgrade |
MRO | 610.30B | Log In | Log In | Log In | Log In | Upgrade |
MRO Growth | 0.81% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical | 411.91B | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Growth | 17.78% | Log In | Log In | Log In | Log In | Upgrade |
Consolidated Adjustment | -27.65B | Log In | Log In | Log In | Log In | Upgrade |
Consolidated Adjustment Growth | 8.49% | Log In | Log In | Log In | Log In | Upgrade |
Other | 17.72B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 1.33% | Log In | Log In | Log In | Log In | Upgrade |
Consolidated Adjustment | -27.65B | Log In | Log In | Log In | Log In | Upgrade |
Consolidated Adjustment Growth | 8.49% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Consolidated Adjustment | -27.65B | Log In | Log In | Log In | Log In | Upgrade |
Consolidated Adjustment Growth | 8.49% | Log In | Log In | Log In | Log In | Upgrade |
South Korea | 1,641.16B | Log In | Log In | Log In | Log In | Upgrade |
South Korea Growth | 8.73% | Log In | Log In | Log In | Log In | Upgrade |
Asia | 19.61B | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | -32.98% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 7.59B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 522.64% | Log In | Log In | Log In | Log In | Upgrade |
Consolidated Adjustment | -27.65B | Log In | Log In | Log In | Log In | Upgrade |
Consolidated Adjustment Growth | 8.49% | Log In | Log In | Log In | Log In | Upgrade |